Skip to content

Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence

Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05972070
Enrollment
500
Registered
2023-08-02
Start date
2023-06-01
Completion date
2025-12-31
Last updated
2025-07-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Rehabilitation, Coronary Artery Bypass, Heart Failure, Myocardial Infarction, Percutaneous Transluminal Coronary Angioplasty, Stable Angina, Stent, Valve Disease, Heart

Keywords

Cardiac rehabilitation, Home based cardiac rehabilitation, Telemedicine and Home-Based Cardiac Rehabilitation

Brief summary

The aim of this study is to evaluate feasibility, efficacy, and adherence of home-based cardiac rehabilitation with the integration of telemedicine. Several components will be assessed such as quality-of-life, nutritional counseling, maximum metabolic activity (MET's), diabetic management, tobacco cessation, lipid, blood pressure, and psychosocial management. These tasks will be accomplished through concurrent conversations between patients and their therapist's utilizing telemedicine with observed exercise training.

Detailed description

The focus of this study is to determine the feasibility, efficacy, and adherence of home-based cardiac rehabilitation with the integration of telemedicine. The study consists of an initial review, rehabilitation sessions, nutrition consultation, and risk stratification. Once the patient is cleared for the rehabilitation program, they will be assigned a cardiac rehab specialist and begin the 36 rehabilitation sessions. The sessions include pre-session questions, surveys, pre-, during, and post vitals, exercise protocol, and off-the-device exercises.

Interventions

DEVICEROMTech Portable Connect

The ROMTech PortableConnect Rehab System is a continuous rehabilitative exercise therapy device that uses assisted movement to measure, evaluate, exercise, re-educate and strengthen muscles, and to increase joint range of motion.

Sponsors

ROM Technologies, INC
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Over the age of 18 2. NYHA Functional Class I, II, 3. Recent (within 60 days) status post coronary artery revascularization for atherosclerotic coronary artery disease (coronary artery bypass grafting or percutaneous coronary revascularization with stent implantation) 4. Candidate for traditional center-based cardiac rehabilitation

Exclusion criteria

1. Under the age of 18 2. Adults lacking capacity to consent. 3. NYHA Functional Class III, IV 4. Acute coronary syndrome 5. Systolic heart failure (LV EF \<40%) 6. Status post cardiac surgery for structural heart disease or heart transplant 7. Percutaneous coronary angioplasty 8. Adults lacking capacity to consent. 9. Pregnant women

Design outcomes

Primary

MeasureTime frameDescription
Duke Activity Status Index (DASI)Baseline, 12 weeks (End of Treatment)Estimate of functional capacity
Session attended12 weeks (End of treatment)Measure the number of sessions attended to determine the ease of patients to utilize home-based cardiac rehab integrated with telemedicine (non-inferiority to historical controls)
Sessions completed12 weeks(End of treatment)Measure the number of sessions completed to determine compliance of patients to utilize home-based cardiac rehab integrated with telemedicine
Short Form-36Baseline, 12 weeks (End of Treatment)Quality of Life assessment
Patient Health Questionnaire(PHQ)Baseline, 12 weeks (End of Treatment)Quality of Life assessment
Short Physical Performance BatteryBaseline, 12 weeks (End of Treatment)Lower extremity functional assessment

Secondary

MeasureTime frameDescription
Laboratory assessmentBaseline, 12 weeks (End of Treatment)To determine if there is an improvement in low density lipoprotein, triglycerides,

Countries

United States

Contacts

Primary ContactLaToya T. King
Latoya.King@romtech.com2035184735

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026